The upcoming patent expiry for Ozempic in India is set to dramatically lower the cost of semaglutide, making this once-premium diabetes and weight-loss drug accessible to more patients. This shift ...
India faces rising severe obesity. Experts discuss how GLP-1 and dual GIP/GLP-1 medications, combined with lifestyle and ...
10don MSN
Weight-Loss Drugs to Get Cheaper in India as Semaglutide Patents Expire; Doctors Warn Against Misuse
Weight-loss drugs in India may become up to 60% cheaper as semaglutide patents expire on March 20, allowing generic launches by major pharma companies. While prices could drop to ₹3,500–₹4,000 monthly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results